* Oncology Institute Inc TOI.OQ TOI.O is expected
to show a
rise in quarterly revenue when it reports results on March 27
for the period ending December 31 2023
* The Cerritos California-based company is expected to
report a
14.9% increase in revenue to $82.042 million from $71.42 million
a year ago, according to the estimate from one analyst, based on
LSEG data.
* LSEG's mean analyst estimate for Oncology Institute Inc
is for
a loss of 11 cents per share.
* The one available analyst rating on the shares is "strong
buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Oncology
Institute Inc is $2.50, above its last closing price of $1.37.
This summary was machine generated March 25 at 20:24 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)